Discover how deepeye® TPS supports retinal specialists in planning anti-VEGF therapy — with predictive insights, biomarker visualization, and a clear 12-month treatment outlook.
This interactive demo lets you:
👁️ Explore an AI-generated OCT report for nAMD
📉 Understand disease activity at a glance
🔮 See long-term treatment need predictions
Age: 90 years
Gender: Female (♀)
Laterality: Right (OD)
In Therapy: 1.9 years anti-VEGF
Age: 76 years
Gender: Female (♀)
Laterality: Right (OD)
In Therapy: 1.2 years anti-VEGF
Age: 85 years
Gender: Female (♀)
Laterality: Left (OS)
In Therapy: 1.3 years anti-VEGF
Age: 85 years
Gender: Male (♂)
Laterality: Left (OS)
In Therapy: 1.8 years anti-VEGF
Age: 82 years
Gender: Male (♂)
Laterality: Left (OS)
In Therapy: 1.1 years anti-VEGF
